TY  - JOUR
AU  - Lisenko, Katharina
AU  - Wuchter, Patrick
AU  - Hansberg, Marion
AU  - Mangatter, Anja
AU  - Benner, Axel
AU  - Ho, Anthony D
AU  - Goldschmidt, Hartmut
AU  - Hegenbart, Ute
AU  - Schönland, Stefan
TI  - Comparison of Different Stem Cell Mobilization Regimens in AL Amyloidosis Patients.
JO  - Biology of blood and marrow transplantation
VL  - 23
IS  - 11
SN  - 1083-8791
CY  - [S.l.]
PB  - Elsevier Health Sciences
M1  - DKFZ-2017-06129
SP  - 1870 - 1878
PY  - 2017
AB  - High-dose melphalan (HDM) and autologous blood stem cell transplantation (ABSCT) is an effective treatment for transplantation-eligible patients with systemic light chain (AL) amyloidosis. Whereas most centers use granulocyte colony-stimulating factor (G-CSF) alone for mobilization of peripheral blood stem cells (PBSC), the application of mobilization chemotherapy might offer specific advantages. We retrospectively analyzed 110 patients with AL amyloidosis who underwent PBSC collection. Major eligibility criteria included age <70 years and cardiac insufficiency New York Heart Association ≤III°. Before mobilization, 67 patients (61
LB  - PUB:(DE-HGF)16
C6  - pmid:28754546
DO  - DOI:10.1016/j.bbmt.2017.07.015
UR  - https://inrepo02.dkfz.de/record/131062
ER  -